Zobrazeno 1 - 10
of 216
pro vyhledávání: '"Ajjan RA"'
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity, Vol Volume 12, Pp 2515-2529 (2019)
Sam Pearson,1,* Noppadol Kietsiriroje,1,2,* Ramzi A Ajjan1 1Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, West Yorkshire LS2 9JT, UK; 2Division of Endocrinology and Metabolism, D
Externí odkaz:
https://doaj.org/article/ea897ea817234a6793c6e8fcf10e6798
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-11 (2021)
Background Mortality in individuals with diabetes with severe hypoglycemia requiring ambulance services intervention is high and it is unclear whether this is modifiable. Our aim was to characterise this high-risk group and assess the impact of nurse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1f919b0bafbb728fdabc1dc922e3900b
The formation of an obstructive thrombus within an artery remains a major cause of mortality and morbidity worldwide. Despite effective inhibition of platelet function by modern antiplatelet therapies, these agents fail to fully eliminate atherothrom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::7d485b0d6d27f52bdf676809543da2ef
Autor:
Ajjan, RA, Kietsiriroje, N, Badimon, L, Vilahur, G, Gorog, DA, Angiolillo, DJ, Russell, DA, Rocca, B, Storey, RF
Publikováno v:
EUROPEAN HEART JOURNAL
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Instituto de Salud Carlos III (ISCIII)
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Instituto de Salud Carlos III (ISCIII)
Cardiovascular disease remains the main cause of mortality in individuals with diabetes mellitus (DM) and also results in significant morbidity. Premature and more aggressive atherosclerotic disease, coupled with an enhanced thrombotic environment, c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::969cd0bb4ea85c1249eedfcd330b539d
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5560
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5560
Autor:
Pechlivani, N, Kearney, KJ, Tiede, C, Cheah, R, Phoenix, F, Ponnambalam, S, Ault, JR, McPherson, MJ, Tomlinson, DC, Ajjan, RA
Publikováno v:
Biochimica et Biophysica Acta (BBA) - General Subjects. 1866:130115
Background Fibrinogen is an abundant plasma protein with an essential role in blood coagulation and haemostasis thus receiving significant research interest. However, protein purification is time consuming and commercial preparations often have prote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6a67eac3168f32a743d18e735d46fec
https://doi.org/10.1016/j.bbagen.2022.130115
https://doi.org/10.1016/j.bbagen.2022.130115
Publikováno v:
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU: Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Institut dInvestigació Biomèdica Sant Pau (IIB Sant Pau)
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU: Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Institut dInvestigació Biomèdica Sant Pau (IIB Sant Pau)
What is known and objective In the outpatient setting, sodium-glucose co-transporter 2 inhibitors (SGLT2i) are recognized as effective agents to optimize glycaemia and also developing robust evidence for cardiovascular (CV) and renal protection in pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9f3cf8dc030d250b069fb5b7ae9e8f20
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1361
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1361
Publikováno v:
Frontiers in Endocrinology
Background: Polycystic ovary syndrome (PCOS) is associated with an adverse cardiovascular risk profile including a prothrombotic state. Exenatide has been shown to be effective at improving insulin sensitivity and weight loss in PCOS; therefore this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4611b67c95f21bd648e549ff62f578e8
http://europepmc.org/articles/PMC6454834
http://europepmc.org/articles/PMC6454834
Despite advances in insulin therapies, patients with type 1 diabetes (T1DM) have a shorter life span due to hyperglycaemia-induced vascular disease and hypoglycaemic complications secondary to insulin therapy. Restricting therapy for T1DM to insulin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::6de853ed502bea89bedaddc9c6674856
https://eprints.whiterose.ac.uk/146817/1/Warnes2018_Article_MetabolicControlInType1Diabete.pdf
https://eprints.whiterose.ac.uk/146817/1/Warnes2018_Article_MetabolicControlInType1Diabete.pdf
Publikováno v:
Diabetes & Vascular Disease Research; Nov/Dec2020, Vol. 17 Issue 6, p1-5, 5p